Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

Olympus unveils new Enzymatic Creatinine assay for improved accuracy

Olympus Life Science Europa - Diagnostics : 22 September, 2008  (New Product)
Olympus has introduced its new Enzymatic Creatinine assay, which has been designed for use across the range of Olympus diagnostic analysers.
The Assay is intended for use for quantitative determination of creatinine in human serum, plasma and urine. The new Assay utilises an enzymatic method to achieve greater accuracy, showing less interference to bilirubin and antibiotics.

The new Olympus Assay complements the current Jaffe method, providing increased accuracy of creatinine measurements for specific patients where potential interferents exists from diabetics, renal failure, liver failure and jaundice specimens.

With a broad measuring range, the new Olympus enzymatic Assay is precise and accurate. The limit of detection for creatinine using serum settings on an Olympus AU640 analyser was established at 0.88µmol/L. The Assay meets the NKDEP guidelines and will minimise errors in eGFR calculations.

The new Assay employs the same calibrators and controls as the current Jaffe method, however, to ensure optimal traceability, new set-points for calibrator and target values, as well as ranges for control sera have been assigned. Sold in a kit format, the reagent has improved on board stability of 60 days and a calibration stability of 14 days for serum and 30 days for urine.

Creatinine measurement is the most commonly used indicator of renal function and has proved useful in monitoring patients with renal failure and those undergoing renal dialysis.
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   Ā© 2012 ProHealthServiceZone.com
Netgains Logo